ChAdOx1 NCov-19 Vaccine-induced Thrombotic Thrombocytopenic Purpura Successfully Treated with Plasmapheresis

Overview

Journal Ann Hematol

Specialty Hematology

Date 2021 Oct 18

PMID 34661713

Citations 5

Authors

Yen-Ching Wang

Tsung-Chih Chen

Chieh-Lin Jerry Teng

Cheng-Han Wu

Affiliations

Soon will be listed here.

Citing Articles

Thrombotic thrombocytopenic purpura following ChAdOx1 nCov-19 vaccination: A case report.

Amiri B, Radkhah H, Taslimi R, Shahbazi Dastjerdi Z, Khadembashiri M, Mesgarha M IDCases. 2023; 32:e01795.

PMID: 37214181 PMC: 10196846. DOI: 10.1016/j.idcr.2023.e01795.

Recurrence of Thrombotic Thrombocytopenic Purpura After Vaccination with mRNA-1273 COVID-19 vaccine.

Ntelis S, Champ K J Community Hosp Intern Med Perspect. 2022; 12(4):80-84.

PMID: 36262899 PMC: 9533810. DOI: 10.55729/2000-9666.1073.

Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature.

Buetler V, Agbariah N, Schild D, Liechti F, Wieland A, Andina N Front Med (Lausanne). 2022; 9:890661.

PMID: 35655852 PMC: 9152022. DOI: 10.3389/fmed.2022.890661.

Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.

Saluja P, Gautam N, Yadala S, Venkata A Thromb Res. 2022; 214:115-121.

PMID: 35533526 PMC: 9060716. DOI: 10.1016/j.thromres.2022.04.020.

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Comment from Doyle et al.

Doyle A, Springell D, Dutt T, Kenworthy J, Ling G, Desborough M J Thromb Haemost. 2022; 20(3):781-783.

PMID: 35220653 PMC: 9115209. DOI: 10.1111/jth.15632.

References

Tiede A, Sachs U, Czwalinna A, Werwitzke S, Bikker R, Krauss J . Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Blood. 2021; 138(4):350-353. PMC: 8084604. DOI: 10.1182/blood.2021011958. View

Voysey M, Clemens S, Madhi S, Weckx L, Folegatti P, Aley P . Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020; 397(10269):99-111. PMC: 7723445. DOI: 10.1016/S0140-6736(20)32661-1. View

Yavasoglu I . Vaccination and Thrombotic Thrombocytopenic Purpura. Turk J Haematol. 2020; 37(3):218-219. PMC: 7463209. DOI: 10.4274/tjh.galenos.2020.2020.0060. View

Bruijn S, Maes M, De Waele L, Vanhoorelbeke K, Gadisseur A . First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination. J Thromb Haemost. 2021; 19(8):2014-2018. PMC: 8236927. DOI: 10.1111/jth.15418. View

Yocum A, Simon E . Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination. Am J Emerg Med. 2021; 49:441.e3-441.e4. PMC: 8095021. DOI: 10.1016/j.ajem.2021.05.001. View